Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment.
Endometriosis is characterized by the presence of endometrial tissue outside the uterine cavity. The administration of drugs designated for this condition has significant adverse effects, such as signs of estrogen insufficiency and suppression of ovulation. Considering this issue, this study aims to...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Online Access: | https://doi.org/10.1371/journal.pone.0330841 |
